GlassScriptPhysician profile
Barry A Rubin
NPI 1902957251
$5,361.94
in general payments reported to CMS, 2019-2025
43 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,087 · 2020: $761 · 2021: $972 · 2022: $1,143 · 2023: $955 · 2024: $337 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,398.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $822.17 | 2019-2024 | |
| Novo Nordisk INC | $622.55 | 2019-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $585.98 | 2019-2024 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $492.67 | 2021-2023 | Qulipta, Ubrelvy, Vraylar |
| Lilly USA, LLC | $234.79 | 2020-2023 | Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $227.20 | 2019-2023 | Jardiance, Synjardy |
| Abbott Laboratories | $203.07 | 2021-2025 | Freestyle Libre 3, Proclaim |
| Allergan, INC. | $201.15 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $163.55 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $147.67 | 2019-2023 | Belsomra |
| Exact Sciences Corporation | $143.13 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $140.57 | 2021-2024 | Dexcom G6 Transmitter |
| Amgen INC. | $122.81 | 2020-2022 | |
| Glaxosmithkline, LLC. | $116.12 | 2019-2025 | Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $100.80 | 2020-2022 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Rubin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.